Prognostic score for second-line chemotherapy of advanced non-small cell lung cancer (NSCLC): External validation in a phase III trial comparing vinflunine with docetaxel.
M. J. Krzakowski
No relevant relationships to disclose
M. Di Maio
No relevant relationships to disclose
K. Perraud
No relevant relationships to disclose
D. M. Kowalski
No relevant relationships to disclose
C. Gridelli
No relevant relationships to disclose